diclofenac has been researched along with tapentadol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hersh, EV; Saraghi, M | 1 |
| Alonso-Castro, ÁJ; Granados-Soto, V; Isiordia-Espinoza, MA; Sánchez-Enriquez, S; Zapata-Morales, JR | 1 |
1 review(s) available for diclofenac and tapentadol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for diclofenac and tapentadol
| Article | Year |
|---|---|
Three newly approved analgesics: an update.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Cyclooxygenase Inhibitors; Diclofenac; Drug Approval; Drug Combinations; Facial Pain; Humans; Phenols; Tapentadol; United States; United States Food and Drug Administration | 2013 |
Assessment of the antinociceptive and ulcerogenic activity of the tapentadol-diclofenac combination in rodents.
Topics: Acetic Acid; Analgesics; Animals; Diclofenac; Dose-Response Relationship, Drug; Drug Synergism; Male; Mice; Phenols; Stomach; Stomach Ulcer; Tapentadol; Visceral Pain | 2018 |